COMPANY

KBio

Keywords: aspergillosis candidiasis fungal infections antibody Covid19 Contraception HIV Herpes Simplex Infections Influenza ZB-06 MB66

Profile checked Oct 10, 2026

Timeline

Feb 8, 2021 Trial start Early phase 1: An Exploratory Study of ZB-06 as a Vaginal Contraceptive Film source ↗
Dec 30, 2020 Trial start Phase 1/Phase 2: KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers source ↗
Jun 25, 2020 Trial start Phase 1: Study to Evaluate the Safety and Immunogenicity of KBP-V001 Quadrivalent Influenza Vaccine in Healthy Adults source ↗
2016-01 Trial start Phase 1: Safety Study of Monoclonal Antibodies to Reduce the Vaginal Transmission of HSV and HIV source ↗

Record	Title	Phase	Status	Start	Primary completion
NCT04473690	KBP-201 COVID-19 Vaccine Trial in Healthy Volunteers	Phase 1/Phase 2	Completed	Dec 30, 2020	May 31, 2022 (actual)
NCT04731818	An Exploratory Study of ZB-06 as a Vaginal Contraceptive Film	Early phase 1	Completed	Feb 8, 2021	Jan 25, 2022 (actual)
NCT02579083	Safety Study of Monoclonal Antibodies to Reduce the Vaginal Transmission of HSV and HIV	Phase 1	Completed	2016-01	2018-07 (actual)
NCT04439695	Study to Evaluate the Safety and Immunogenicity of KBP-V001 Quadrivalent Influenza Vaccine in Healthy Adults	Phase 1	Completed	Jun 25, 2020	Feb 25, 2021 (actual)